Logo image
Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma
Letter/Communication

Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma

Amie Ogunsakin, Jordan Infield, Jeffery Zuber and Solomon S Solomon
The American journal of the medical sciences, Vol.356(6), pp.574-575
12/2018
DOI: 10.1016/j.amjms.2018.09.002
PMID: 30342717
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7673203View
Open Access

Abstract

Antineoplastic Agents - therapeutic use Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - etiology Diabetes Mellitus - drug therapy Diabetes Mellitus - etiology Hospitals, Veterans Hypoglycemic Agents - therapeutic use Laryngeal Neoplasms - drug therapy Laryngeal Neoplasms - etiology Metformin - therapeutic use Oropharyngeal Neoplasms - drug therapy Oropharyngeal Neoplasms - etiology Tennessee

Details

Metrics

Logo image